Therefore , the number needed to treat ( NNT ) with pravastatin for 3.2 years for benefit related to fatal and nonfatal CHD events was 14.8 ( 95 % CI = 9.3-36 .6 ) for high homocysteine and 64.5 ( 95 % CI = 21.4 - ) for low homocysteine .